Nu-Med Plus Reports Net Income Turnaround in Q2 2026, Expands into Gold Exploration

Nu-Med Plus, Inc. reported its financial results for the second quarter of 2026, revealing a net income of $19,670, a significant turnaround from a net loss of $11,665 in the same period last year. For the first half of 2026, the company recorded a net income of $3,792, compared to a net loss of $31,598 in the first half of 2025. The company continues to report no revenue, maintaining its status as an early-stage firm focused on developing medical technologies utilizing nitric oxide. Operating expenses for the second quarter increased to $22,556 from $10,419 year-over-year, primarily due to higher professional and consulting fees.

The company’s balance sheet as of June 30, 2026, shows total assets of $12,909, up from $7,911 at the end of 2025, driven by an increase in cash and prepaid expenses. Current liabilities remained relatively stable at $280,395, compared to $279,189 at the end of the previous fiscal year. The working capital deficiency decreased to $267,486 from $271,278, indicating slight improvement in the company's financial position. The company’s cash position improved to $5,409 from $661, reflecting a net cash increase of $4,748 during the period.

Strategically, Nu-Med Plus has made significant moves to expand its operations. On June 29, 2026, the company entered into a Share Exchange Agreement with Avid Gold Ltd., acquiring 100% of Avid Gold in exchange for 4,500,000 shares of Series A Preferred Stock. This acquisition is expected to diversify Nu-Med's operations into gold exploration and development. Additionally, the company has entered into a Mineral Property Purchase Agreement to acquire six gold mineral properties in Canada, further enhancing its asset portfolio. The closing of these transactions is anticipated to provide new growth opportunities.

Operationally, the company has not reported any customer counts or user statistics, as it remains in the development phase without generating revenue. However, the recent strategic acquisitions may lead to increased engagement metrics and market share in the gold exploration sector. The company’s employee headcount remains unchanged, with no new hires reported in the latest filing. The management has indicated that the integration of Avid Gold's operations is a priority, which could potentially enhance operational efficiency and resource allocation.

Looking ahead, Nu-Med Plus acknowledges the need for additional financing to support its business plan, with planned expenditures of approximately $1.2 million over the next twelve months. The company is currently funded through August 31, 2026, and is exploring options to raise capital, including through the sale of equity. The management's outlook remains cautious, emphasizing the importance of securing funding to ensure continued operations and the successful execution of its strategic initiatives.